Clinical Trials Browser

OTHER × Carcinoma, Transitional Cell × disitamab vedotin × Clear all

NCT05912205 2023-06-22

Disitamab Vedotin Combined With Radiotherapy for Bladder Preservation

Phase 2 Not yet recruiting

Carcinoma, Transitional Cell

NCT05723991 2023-02-13

Study of Disitamab Vedotin Combined With Gemcitabine in Neoadjuvant Treatment of Urothelial Carcinoma

Phase 4 Unknown

Carcinoma, Transitional Cell